We examined the interplay between the insulin/IGF-1-and b-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. Insulin and IGF-1 stimulated the transcription of a Lef/Tcfdependent luciferase reporter gene by 3 ± 4-fold in HepG2 cells. This stimulation was mediated through the activation of phosphatidylinositol 3-kinase (PI 3-K)/Akt and the inhibition of glycogen synthase kinase-3b (GSK3b) since the eects of insulin and IGF-1 were inhibited by dominant-negative mutants of PI 3-K or Akt and an uninhibitable GSK-3b. Together with inhibiting GSK-3b, insulin and IGF-1 increased the cytoplasmic levels of bcatenin. The PI 3-K/Akt/GSK-3b pathway was not the sole to mediate insulin and IGF-1 stimulation of Lef/Tcfdependent transcription. The Ras signalling pathway was also required as (i) the stimulatory eects of insulin and IGF-1 were inhibited by dominant-negative Ras or the MEK1 inhibitor PD98059 and (ii) activated Ha-Ras or constitutively active MEK1 synergized with catalytically inactive GSK-3b to stimulate Lef/Tcf-dependent transcription. This study provides the ®rst evidence that insulin and IGF-1 stimulate the b-catenin pathway through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3b inhibition and Ras activation. These ®ndings demonstrate for the ®rst time the ability of insulin and IGF-1 to activate the b-catenin pathway in hepatoma cells and thereby provide new insights into the role of these factors in hepatocarcinogenesis. Oncogene (2001) 20, 252 ± 259.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common fatal cancers worldwide. Hepatitis B and hepatitis C virus infections, dietary exposure to a¯atoxin B1, excessive intake of alcohol and genetic diseases predisposing to cirrhosis have been identi®ed as major risk factors of HCC (Moradpour and Wands, 1994) . However the molecular mechanisms underlying HCC development are still poorly understood.
Normal hepatocyte proliferation is regulated by several growth factors including insulin (Michalopoulos and DeFrances, 1997) . Insulin and insulin-like growth factors (IGFs) have been also reported to act as potent survival factors for hepatoma cells (Tanaka and Wands, 1996; Chen et al., 1998; Buchmann et al., 1999) . Binding of insulin and IGFs to tyrosine kinase receptors leads to the rapid receptor autophosphorylation and the subsequent tyrosine phosphorylation of a variety of endogenous substrates including insulinreceptor substrate-1 (IRS-1), IRS-2 and Shc (Ogawa et al., 1998; White, 1998) . Substrate phosphorylation generates docking sites for several molecules such as phosphatidylinositol 3-kinase (PI 3-K) and the adapter Grb2 that links Sos, a guanine nucleotide exchange factor for Ras. These early signalling events result in the activation of the PI 3-K/Akt and Ras/extracellularregulated kinases (ERKs) pathways.
Studies conducted in human HCC cell lines and tumour tissues revealed alterations in the insulin/IGF signalling pathways. Thus, increased expression of IGF-II (Cariani et al., 1988 (Cariani et al., , 1991 Su et al., 1994; Nardone et al., 1996) , IGF-1 receptor or IRS-1 (Kim et al., 1996; Nishiyama and Wands, 1992; Tanaka et al., 1997) were frequently observed. More recently, mutations in PTEN, a negative regulator of the PI 3-K/Akt pathway, were reported in HCC (Yao et al., 1999) . The functional consequences of some of these alterations were found to result in constitutive activation of PI 3-K and ERKs (Tanaka et al., 1997) .
Recent data suggest that activation of the b-catenin signalling pathway also contributes to liver transformation. Indeed, activating mutations of b-catenin are present in HCC (de La Coste et al., 1998; Miyoshi et al., 1998; Nhieu et al., 1999; Terris et al., 1999) as well as in some hepatoma cell lines (de La Coste et al., 1998) . In addition, activating mutations of b-catenin were identi®ed in rodent hepatocellular neoplasms induced by diverse chemical carcinogens (Devereux et al., 1999; Ogawa et al., 1999; Tsujiuchi et al., 1999) . Furthermore, inactivating mutations of axin, a negative regulator of the b-catenin signalling pathway, were reported in HCC (Satoh et al., 2000) .
b-catenin is a multifunctional protein (Polakis, 1999; Barker et al., 2000) . First, b-catenin plays an essential role in cell-cell adhesion through its ability to directly associate with the intracellular tail of E-cadherin and to link via a-catenin the actin ®lament network. Besides its role at adherens junctions, b-catenin functions as a component of the Wnt/Wingless signalling pathway. This pathway plays a critical role in development, proliferation and dierentiation (Wodarz and Nusse, 1998) . In the absence of a Wnt/Wingless signal, bcatenin is localized mainly at adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993) , glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996) , and axin (Hart et al., 1998; Behrens et al., 1998) . bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system (Aberle et al., 1997) . Activation of the Wnt/Wingless pathway inhibits GSK-3b, which leads to the accumulation of hypophosphorylated bcatenin in the cytoplasm. Once stabilized, b-catenin translocates to the nucleus where it associates with the transcription factors of the Lef/Tcf family to stimulate gene expression. All the activating b-catenin mutations identi®ed so far in HCC aect the sites phosphorylated by GSK-3b and induce the stabilization of b-catenin, similar to what is observed in the presence of a Wnt/ Wingless signal.
In the present study, we examined the interplay between the insulin/IGF-1 and b-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. We speci®cally analysed the eect of insulin and IGF-1 on Lef/Tcf-dependent transcription in HepG2 cells, an hepatoma cell line which is well-responsive to insulin and IGF-1 proliferative signals. Having determined that Lef/Tcfdependent transcription was stimulated by insulin and IGF-1 in this cell line, we sought to de®ne the signalling pathways used by insulin and IGF-1 to activate Lef/Tcf-dependent transcription.
Results
Insulin and IGF-1 stimulate the transcription of a Lef/Tcf-dependent reporter gene in HepG2 cells
The HepG2 hepatoma cell line expresses two b-catenin isoforms, the 92 kDa wild-type isoform and a 73-kDa truncated one (de la Coste et al., 1998 and see Figure  4c ). The latter results from a large NH 2 -terminal deletion (amino acids 25 ± 140) which removes the GSK-3b regulatory sites. This deletion leads to the accumulation of the truncated protein in cytoplasm and nucleus (de la Coste et al., 1998) . We observed that, in HepG2 cells, the basal transcriptional activity of the pTOPFLASH reporter, a plasmid containing three consensus Lef/Tcf-binding sites upstream of a luciferase reporter gene was about 15 times that of its control counterpart pFOPFLASH, a plasmid containing mutated Lef/Tcf binding sites (Figure 1a ). This indicates that, in the HepG2 cell line, the b-catenin signalling pathway is upregulated at the basal state as a result of the nuclear localization of the truncated b-catenin.
We next wished to examine the eect of insulin and IGF-1 on Lef/Tcf-dependent transcription in HepG2 cells. Using the luciferase reporter gene assay, we observed that insulin and IGF-1 (17 h) increased pTOPFLASH activity in a concentration-dependent manner (Figure 1b) indicating that insulin and IGF-1 were able to stimulate Lef/Tcf-dependent transcription in HepG2 cells.
Activation of PI 3-K/Akt is necessary for insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription GSK-3b inhibition has been shown to be a central event in the Wnt/Wingless signalling pathway since it is responsible for b-catenin stabilization and hence for Lef/Tcf-dependent transcription (Polakis, 1999; Barker . In addition to being inhibited by Wnt/ Wingless signals, GSK-3b is inhibited by insulin and IGF-1 (Cross et al., 1994) through the sequential activation of PI 3-K and Akt (van Weeren et al., 1998) . We therefore evaluated the role of the signalling pathway involving PI 3-K?Akt?GSK-3b in insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription.
To examine the contribution of PI 3-K in this eect, HepG2 cells were transfected with the pTOPFLASH reporter plasmid together with a control pcDNA3 plasmid or a plasmid coding for the truncated regulatory subunit of PI 3-K (Dp85). Cells were incubated in the presence of insulin or IGF-1 for 17 h and assayed for luciferase activity. As shown in Figure 2a , the dominantnegative mutant of PI 3-K inhibited insulin and IGF-1 activation of the pTOPFLASH reporter by 83 and 91% respectively. Reciprocally, the transient expression of a constitutively active catalytic subunit of PI 3-K (p110*) stimulated pTOPFLASH luciferase activity by 3.44-+0.76-fold (Figure 2b ). These results indicate that PI 3-K is a mediator of both insulin and IGF-1 for the stimulation of Lef/Tcf-dependent transcription.
We next examined the participation of Akt, a serine/ threonine kinase downstream of PI 3-K which mediates some of the metabolic, proliferative and antiapoptotic functions of insulin and IGF-1 (Shepherd et al., 1998) . To this end, HepG2 cells were transfected with pTOPFLASH together with a control pcDNA3 plasmid Figure 2 Insulin and IGF-1 stimulate the transcription of pTOPFLASH through a PI 3-K/Akt-dependent pathway. HepG2 cells were transfected with pTOPFLASH (1 mg) or pFOPFLASH (1 mg) together with pbgal-Control (0.5 mg) and the indicated expression plasmids (1 ± 2 mg). Cells were then incubated for 17 h in the presence or absence of insulin or IGF-1 (10 78 M) and assayed for luciferase and b-galactosidase activities. Values are normalized luciferase activity as described in the legend to Figure 1b and are the mean+s.e.m. of 3 ± 5 independent experiments performed in duplicate Figure 3 GSK-3b inhibition stimulates the transcription of pTOPFLASH. HepG2 cells were transfected with pTOPFLASH (1 mg) or pFOPFLASH (1 mg) together with pbgal-Control (0.5 mg) and the presence or absence of the indicated expression plasmids (1 mg). Cells were incubated for 17 h in the presence or absence of LiCl (20 mM) and were then assayed for luciferase and b-galactosidase activities. Values are normalized luciferase activity as described in the legend to Figure 1b and are the mean+s.e.m. of ®ve (a) and two (b) independent experiments performed in duplicate or a plasmid encoding a dominant-negative mutant of Akt (KD-PKB). Cells were then incubated with insulin or IGF-1 for 17 h and assayed for luciferase activity. Similar to what was observed with the Dp85 construct, overexpression of the Akt mutant reduced the eect of insulin and IGF-1 by 73 and 86%, respectively ( Figure  2c) . Moreover, the transient expression of a plasmid coding for a constitutively active Akt (gagPKB) stimulated pTOPFLASH luciferase activity by about twofold (Figure 2d ). These data indicate that Akt is the downstream eector of PI 3-K in the signalling pathways initiated by insulin and IGF-1 to stimulate Lef/Tcfdependent transcription.
Inhibition of GSK-3b activity is required for insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription
We then investigated whether GSK-3b inhibition was relevant for insulin and IGF-1 stimulation of Lef/Tcfdependent transcription. In preliminary experiments, we observed that overexpression of a catalytically inactive GSK-3b (R85GSK-3b) which acts as a dominantnegative mutant of endogenous GSK-3b (Pap and Cooper, 1998) stimulated pTOPFLASH luciferase activity (Figure 3a) . This indicates that activation of Lef/Tcf-dependent transcription through GSK-3b inhibition is operational in HepG2 cells. Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory eect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996) , increased reporter activity (Figure 3b ).
Insulin and IGF-1 are known to be potent inhibitors of GSK-3b activity in a number of cell types (Cross et al., 1994) . To examine their eect on GSK-3b activity in HepG2 cells, whole-cell lysates from control, insulinand IGF-1-treated cells were analysed by Western blot using an antiphospho-GSK-3b antibody which detects GSK-3b only when inactivated by phosphorylation at serine 9. As shown in Figure 4a , insulin and IGF-1 stimulated GSK-3b phosphorylation indicating that both ligands inhibited GSK-3b in HepG2 cells.
To investigate the role of GSK-3b inhibition in insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription, HepG2 cells were cotransfected with the pTOPFLASH reporter and a plasmid coding for an uninhibitable GSK-3b (A9GSK-3b). This plasmid encodes a mutant GSK-3b in which the serine 9 phosphorylation site is mutated to alanine (Summers et al., 1999) . We observed that overexpression of A9GSK-3b abolished the eect of insulin and IGF-1 on pTOPFLASH activity (Figure 4b ) indicating that GSK-3b inhibition was required for insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription. As GSK-3b inhibition is responsible for b-catenin stabili- (Figure 4c ). Taken together, these ®ndings suggest that insulin and IGF-1 stimulate Lef/ Tcf-dependent transcription in HepG2 cells through a pathway involving PI 3-K/Akt activation, GSK-3b inhibition and subsequent stabilization of wild-type bcatenin. However this may not be the sole pathway implicated since the maximal stimulatory eects of insulin and IGF-1 on pTOPFLASH activity were additive with that elicited by the catalytically inactive R85GSK-3b (Figure 4d ).
Insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription requires Ras activation
The above results prompted us to examine the possible implication of an additional signalling pathway mediating insulin and IGF-1 activation of Lef/Tcf-dependent transcription. Since Ras has been described as an eector of PI 3-K in diverse insulin-mediated biological eects (Shepherd et al., 1998; Egawa et al., 1999) , we tested the involvement of the Ras signalling pathway. For this purpose, HepG2 cells were transiently transfected with a plasmid encoding a dominant-negative mutant of HaRas (N17Ras). This plasmid reduced the ability of insulin and IGF-1 to stimulate the luciferase reporter gene by about 60 and 50%, respectively (Figure 5a) . Similarly, cell treatment with the MEK1 inhibitor PD98059 partially inhibited the stimulatory eect of insulin and IGF-1 (Figure 5b ). In accordance with these ®ndings indicating the involvement of the Ras/MEK/ ERK cytoplasmic cascade in insulin and IGF-1 activation of Lef/Tcf-dependent transcription in HepG2 cells, the transient expression of activated Ha-Ras (V12Ras) or constitutively active MEK1 (D218/D222MEK1) stimulated pTOPFLASH activity by 10-and threefold respectively (Figure 5c ). In addition, the ®ndings that (i) the stimulatory eects of p110* and V12Ras were not additive ( Figure 6a ) and (ii) PD98059 inhibited by 40% the stimulatory eect of p110* on pTOPFLASH activity (Figure 6b ) strongly argue for the Ras/MEK/ERK cascade lying downstream of PI 3-K in the signalling Figure 5 Insulin and IGF-1 stimulation of pTOPFLASH transcription also requires Ras activation. HepG2 cells were transfected with pTOPFLASH (1 mg) or pFOPFLASH (1 mg) together with pbgal-Control (0.5 mg) and the indicated expression plasmids (1 mg). Cells were then incubated for 17 h in the presence or absence of insulin or IGF-1 (10 78 M). In some experiments, cells were also treated with the MEK1 inhibitor (PD98059, 100 mM) or the vehicle (DMSO). Values are normalized luciferase activity as described in the legend to Figure 1b and are the mean+s.e.m. of three independent experiments performed in duplicate pathway leading to insulin and IGF-1 stimulation of Lef/ Tcf-dependent transcription.
Finally, we tested the combined eects of GSK-3b inhibition and Ras activation on Lef/Tcf-dependent transcription by coexpressing catalytically inactive GSK-3b (R85GSK-3b) with activated Ha-Ras or constitutively active MEK1. Coexpression of R85GSK-3b with V12Ras or D218/D222MEK1 had a synergistic eect on Lef/Tcf-dependent transcription (Figure 6c ) indicating that the Ras/MEK/ERK signalling pathway stimulates Lef/Tcf-dependent transcription through a mechanism independent of GSK-3b inhibition.
Discussion
The recent identi®cation in HCC of dysregulations in the b-catenin signalling pathway as a result of genetic alterations in b-catenin and axin has opened new perspectives for the comprehension of hepatic transformation. In the present study, we addressed the question of whether b-catenin signalling could also be dysregulated by the insulin/IGF-1 pathways which are frequently activated in HCC. Our results provide the ®rst evidence that insulin and IGF-1 stimulate Lef/Tcfdependent transcription in HepG2 cells. They moreover show that this stimulation involves a signalling cascade consisting of PI 3-K/Akt/GSK-3b and leading to b-catenin accumulation. It is worth noting that insulin and IGF-1, like the Wnt/Wingless signals, mediate Lef/Tcf-dependent transcription through GSK-3b inhibition. However, a major dierence exists between these stimuli in that PI 3-K and Akt are not cytoplasmic mediators in the Wnt/Wingless signalling cascades (Cook et al., 1996; Torres et al., 1999; Yuan et al., 1999) . This may be speci®c of these cascades since several studies provided indirect evidence for a role of Akt in the regulation of the b-catenin signalling pathway. Thus, the expression of mutant presenilin-1 in rat hippocampal neurons and PC12 cells induced apoptosis through downregulation of both Akt activity and b-catenin expression (Weihl et al., 1999) . Overexpression of integrin-linked kinase-1 (ILK-1), a signalling intermediary between PI 3-K and Akt which Figure 6 Ras lies downstream of PI 3-K in the signalling pathway leading to the stimulation of pTOPFLASH transcription. HepG2 cells were transfected with pTOPFLASH (1 mg) or pFOPFLASH (1 mg) together with pbgal-Control (0.5 mg) and the indicated expression plasmids (1 mg). In some experiments, cells were treated with the MEK1 inhibitor (PD98059, 100 mM) or the vehicle (DMSO). Values are normalized luciferase activity as described in the legend to Figure 1b and are the mean+s.e.m. of three independent experiments performed in duplicate is activated by insulin, was reported to stimulate Akt activity as well as Lef/Tcf-dependent transcription in rat intestinal epithelial cells (IEC-18) (Delcommenne et al., 1998; Novak et al., 1998) .
Although the inhibition of GSK-3b activity through Akt activation was essential for insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription in HepG2 cells, additional mechanisms were required. In agreement with our ®ndings, GSK-3b inhibition was reported not to be sucient for mediating Lef/Tcfdependent transcription in T lymphocytes (Staal et al., 1999) and in NIH3T3 cells (Yuan et al., 1999) . We show that, in addition to the Akt/GSK-3b pathway, insulin and IGF-1 control Lef/Tcf-dependent transcription through PI 3-K activation of the Ras signalling pathway. While the overexpression of activated Ha-Ras strongly stimulated Lef/Tcf-dependent transcription in HepG2 cells, it was reported to have no major eect on this process in rat intestinal epithelial cells (Novak et al., 1998) and keratinocytes (Espada et al., 1999) . These data could suggest that the involvement of the Ras signalling pathway in the stimulation of Lef/Tcf-dependent transcription is cell-type speci®c.
The molecular mechanisms whereby the Ras signalling pathway stimulates Lef/Tcf-dependent transcription in HepG2 cells remains to be elucidated. Since this pathway mediates insulin and IGF-1 regulation of gene expression (O'Brien and Granner, 1996) , it would be of interest to examine whether it contributes to the stimulation of Lef/Tcf-dependent transcription by increasing the expression of Lef/Tcf factors. In this regard, stimulation of Lef/Tcf-dependent transcription as a result of increased Lef-1 protein expression was previously reported in intestinal epithelial cells (Novak et al., 1998) .
Recent data show that human liver cancer is associated with a constitutive activation of the b-catenin pathway as a result of activating and inactivating mutations in b-catenin and axin, respectively (de La Coste et al., 1998; Miyoshi et al., 1988; Nhieu et al., 1999; Terris et al., 1999; Satoh et al., 2000) . However, the ®nding that some HCC samples show accumulation of bcatenin in the absence of b-catenin or axin mutations (de la Coste et al., 1998; Satoh et al., 2000) points to additional mechanisms being involved in the activation of this pathway. The results reported here identify insulin and IGF-1 as new triggers of the b-catenin pathway in hepatoma cells. Therefore, they strongly suggest that the frequent upregulation of the insulin/IGF signalling pathways observed in HCC (Cariani et al., 1988 (Cariani et al., , 1991 Nishiyama and Wands, 1992; Su et al., 1994; Nardone et al., 1996; Kim et al., 1996; Tanaka et al., 1997; Yao et al., 1999) contributes to hepatic transformation through the activation of the oncogenic potential of the b-catenin signalling pathway.
In the summary, the present study provides evidence for the ability of insulin and IGF-1 to stimulate the bcatenin pathway in HepG2 cells. We show that insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription is mediated through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3b inhibition and Ras activation. These ®ndings highlight the role of PI 3-K as a main regulator of the b-catenin signalling pathway in response to insulin and IGF-1. Further studies will be required to investigate the molecular mechanisms by which Ras activation regulates Lef/Tcf transcription.
Materials and methods

Plasmids
The luciferase reporter plasmid pTOPFLASH which contains three consensus Lef/Tcf-binding sites upstream of a minimal c-Fos promoter driving luciferase expression and its control counterpart pFOPFLASH in which the Lef/Tcf sites are mutated were a gift from Dr H Clevers. The plasmid coding for the truncated regulatory subunit of PI 3-K (Dp85) was a gift from Dr W Ogawa. The expression vector for the constitutively activated catalytic subunit of PI 3-K (p110*) was obtained from Dr A At®. The myristoylated and kinase-dead Akt/PKB (KD-PKB) and the constitutively active Akt/PKB (gagPKG) constructs were a gift from Dr BM Burgering. The plasmid coding for the catalytically inactive GSK-3b (R85GSK-3b) was a gift from Dr GM Cooper. The uninhibitable GSK-3b expression vector (A9-GSK-3b) was a gift from Dr MJ Birnbaum. The plasmids coding for the activated (V12) and dominant-negative (N17) Ha-Ras were a gift from Dr C Gespach. The dominant-active (D218/D222) MEK1 expression vector was obtained from Dr J PouysseÂ gur.
Cell culture and transient transfections
HepG2 cells were maintained in minimal essential medium containing GlutaMAX I TM , Earle's salts, 1% nonessential amino acids, 1 mM sodium pyruvate, 10% fetal calf serum, 100 units/ml penicillin/streptomycin and 25 mM HEPES (Life Technologies TM ). For transient transfections, cells plated in sixwell plates (2610 5 cells/well) were transfected with 1 mg of pTOPFLASH reporter and 0.5 mg of pbgal-Control (Clontech Laboratories, Inc.), together with 1 mg of the indicated expression vectors by using Transfast (Promega Corp.). As a control, cells were transfected with 1 mg of pFOPFLASH. The total amount of DNA was kept constant with pcDNA3neo (Invitrogen). Seventeen hours posttransfection, cells were serum-deprived for 10 h and then stimulated with insulin or IGF-1 for 17 h. Cells were lysed and assayed for luciferase activity as previously described (Bertrand et al., 1995) . bgalactosidase activity was assessed using the Galacto-Light TM kit (Tropix). Lef/Tcf-dependent luciferase activity was de®ned as the pTOPFLASH activity minus the activity devoted to pFOPFLASH and normalized to the b-galactosidase activity.
Preparation of cell extracts
Whole-cell extracts were prepared as previously reported (Desbois-Mouthon et al., 2000) . For cytosolic extracts, cells cultured on 100 mm dishes were resuspended in 20 mM HEPES (pH 7.4), 0.28 M sucrose, 50 mM NaCl, 2 mM EDTA, 20 mM sodium pyrophosphate, 100 mM sodium uoride, 2 mM sodium orthovanadate, 2 mM phenylmethylsulfonyl¯uoride and 10 mg/ml leupeptin and disrupted by passaging through a 25-gauge syringe. Lysates were then centrifuged at 1000 g for 10 min at 48C to sediment nuclei and the supernatant fractions were centrifuged at 100 000 g for 60 min at 48C. The supernatants (cytosolic fractions) were collected and stored at 7208C until use.
Western blot analysis
Cell extracts were loaded on 7.5% SDS-polyacrylamide gels and electroblotted onto Hybond ECL nitrocellulose membranes (Amersham) for 1.5 h at 50 V. After blocking in 3% non-fat dry milk (Bio-Rad Laboratories), the membranes were probed for 1 h at room temperature or overnight at 48C with an anti-b-catenin (Santa Cruz Biotechnology, Inc.), an anti-phospho-GSK-3b (Ser9) (New England Biolabs) or an anti-GSK-3b (Transduction Laboratories) antibody. Immune complexes were visualized by enhanced chemiluminescence method (Amersham).
